G8 Education Ltd.’s stock plummets with the fall in 1H 2018 profit

G8 Education Ltd.’s stock plummets with the fall in 1H 2018 profit - kalkine Media

Weak Performance in 1H 2018 due to considerable regulatory changes and challenging industry conditions: G8 Education Ltd.’s (ASX: GEM) stock plummeted 14.8% on August 27, 2018 (3 PM AEST) after the company for the first half of 2018 has reported 23.9% fall in the underlying net profit after tax to $25.6 million.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

The underlying EBIT fell by 21.2% to $48.1 million on back of higher Q1 wage costs from regulatory changes to required staff ratios, though this is in line with market consensus. Wage ratios have returned to prior year levels by May, reflecting an improved wage outcome to be expected in the second half. The average like-for-like H1 2018 occupancy was down 2.5% to 70.1%, however, the recent data reflects encouraging early signs of improvement, as July 2018 occupancy rose to 74.5%, which is a 2.2% rise over June 2018. August occupancy growth is ahead of last year’s levels. Additionally, GEM expects the H1/H2 Earnings Before Interest and Tax split to be similar to prior years, being approximately 34 : 66. GEM stock has fallen 5.84% in three months as on August 24, 2018  and is trading at a P/E of 12.79x.

ASX GEM - Report - Kalkine Media1H 2018 Financial Performance (Source: Company Reports)

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report